Cardlytics (NASDAQ:CDLX – Get Free Report) released its quarterly earnings data on Wednesday. The company reported ($0.15) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.33) by $0.18, Briefing.com reports. The business had revenue of $67.06 million during the quarter, compared to analyst estimates of $57.77 million. Cardlytics had a negative net margin of 93.55% and a negative return on equity of 93.64%. Cardlytics’s revenue was down 15.1% compared to the same quarter last year. During the same period last year, the business earned ($0.26) EPS. Cardlytics updated its Q4 2024 guidance to EPS.
Cardlytics Stock Performance
NASDAQ:CDLX traded up $0.30 during mid-day trading on Friday, hitting $4.37. 1,752,101 shares of the company traded hands, compared to its average volume of 726,140. The stock’s fifty day moving average price is $3.69 and its 200-day moving average price is $6.70. The company has a quick ratio of 1.77, a current ratio of 1.77 and a debt-to-equity ratio of 1.01. Cardlytics has a one year low of $2.89 and a one year high of $20.52. The firm has a market cap of $222.09 million, a price-to-earnings ratio of -0.72 and a beta of 1.61.
Insider Activity
In other news, Director Scott A. Hill bought 40,000 shares of the stock in a transaction that occurred on Monday, August 12th. The shares were bought at an average price of $3.58 per share, for a total transaction of $143,200.00. Following the purchase, the director now owns 40,000 shares in the company, valued at $143,200. The acquisition was disclosed in a document filed with the SEC, which is available through this link. In related news, Director Scott A. Hill purchased 40,000 shares of Cardlytics stock in a transaction on Monday, August 12th. The shares were bought at an average cost of $3.58 per share, for a total transaction of $143,200.00. Following the acquisition, the director now owns 40,000 shares in the company, valued at approximately $143,200. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Amit Gupta sold 22,607 shares of the stock in a transaction dated Thursday, October 24th. The shares were sold at an average price of $3.85, for a total transaction of $87,036.95. Following the transaction, the chief executive officer now directly owns 178,519 shares of the company’s stock, valued at $687,298.15. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 43,573 shares of company stock valued at $151,612 in the last ninety days. Corporate insiders own 4.40% of the company’s stock.
Wall Street Analyst Weigh In
Check Out Our Latest Report on Cardlytics
Cardlytics Company Profile
Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.
Read More
- Five stocks we like better than Cardlytics
- What is the Hang Seng index?
- Airbnb Stock Attracts Attention With Strong Cash Flow Strategy
- Want to Profit on the Downtrend? Downtrends, Explained.
- MarketBeat Week in Review – 11/4 – 11/8
- What is MarketRank™? How to Use it
- Trump’s Return: Which Sectors Will Benefit Most?
Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.